Figure 1
From: Osteoporosis Treatment: When to Discontinue and When to Re-start
Variations of femoral or lumbar spine BMD and of two bone turnover markers (urine NTX or bone alkaline phosphatases) in the extension of phase 3 study with Alendronate in postmenopausal osteoporosis (5).
